Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.5M Sell
146,197
-3,500
-2% -$725K 0.4% 71
2026
Q1
$33.6M Buy
+149,697
New +$37.3M 0.51% 52
2025
Q3
$43.4M Hold
158,557
0.6% 37
2025
Q2
$40.9M Hold
158,557
0.6% 40
2025
Q1
$35.5M Buy
158,557
+13,420
+9% +$3.13M 0.6% 40
2024
Q4
$33.2M Buy
+145,137
New +$34.9M 0.53% 44
2023
Q4
$38.4M Buy
+159,421
New +$24.5M 0.51% 46

Other funds holding RMD

Aware Super's RMD Position: Q2 2026 in Review

Aware Super reduced its ResMed (RMD) stake by 2.3% in Q2 2026, selling an estimated $725K and leaving 146,197 shares worth $28.5M. The position accounts for 0.4% of the portfolio, ranked #71.

Aware Super first reported a position in RMD in Q4 2023 and has held it in 7 quarters since. The position peaked at $43.4M in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Aware Super held 146,197 shares of ResMed worth $28.5M as of Q2 2026.
  • Aware Super sold 3,500 ResMed shares in Q2 2026, an estimated $725K.
  • ResMed made up 0.4% of Aware Super's portfolio in Q2 2026, its #71 holding.
  • Aware Super first reported a position in ResMed in Q4 2023 and has held it in 7 quarters since.
  • Aware Super's ResMed position peaked at $43.4M in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.